Special Note Regarding Forward-Looking Statements




Certain statements in this Report contain forward-looking statements within the
meaning of Section 27A of the Securities Act and Section 21E of... | May 13, 2022

Related Keywords

Netherlands ,New York ,United States ,Utah State University ,Utah ,New Jersey ,Argentina ,New Brunswick ,Ocala ,Florida ,China ,Italy ,Syria ,Canada ,Turkey ,Americans ,America ,Argentine Republic ,Syrian ,American ,Pawel Kalinski ,Rintatolimod Ampligen ,Roswell Park ,Alimentosy Tecnologia ,Robertp Edwards ,Casper Van Eijck ,Hemispherx Biopharma Europe ,Monserrato Cagliari ,Contract Research Organization ,Us Centers For Disease ,National Cancer Institute ,Contract Manufacturing Organization ,Overall Research ,Public Library Of Science ,Early Access Program ,Centre For Human Drug Research ,Access Program Early Programs ,Roswell Park Comprehensive Cancer Center ,Oxford Research Ethics Committee ,China Overseas Development Association ,European Commission ,Buffett Cancer Center ,Drug Administration ,Amarex Clinical Research ,Institute For Viral Research ,Armada Healthcare ,Shenzhen Smoore Technology ,American Association For Cancer Research ,International Association World Congress ,Netherlands Patent Office ,Securities Exchange ,Healthcare Regulatory Agency ,Access Program ,Agency For Healthcare Research ,United States Adopted Names Council ,University Of Pittsburgh Medical Center ,University Of Nebraska Medical Center ,University Of Pittsburgh School Medicine ,Us National Institutes Of Health ,Pharmaceutics International Inc ,Cancer Research ,Leyden Lab ,Cost Recovery Program ,Ovarian Cancer Specialized Program Of Research Excellence ,Acellories Inc ,University Of Pittsburgh ,Clinical Research Organization ,European Union ,Polysciences Inc ,Immunotech Inc ,Steering Committee ,Simmaron Research ,Division Of Neurology ,Erasmus Medical Center ,European Medicines Agency ,Covid Scientific Technical Triage Team ,Clinical Cancer Research ,Research Agreement ,Special Note Regarding Forward Looking ,Securities Act ,Securities Exchange Act ,Financial Condition ,Annual Report ,Severe Acute Respiratory Syndrome ,Complete Response Letter ,Ampligen New Drug Application ,Administracion Nacional De Medicamentos ,Tecnologia Medica ,Early Access Programs ,Pittsburgh Medical ,Alferonn Injection ,Biological License Application ,Chronic Fatigue Syndrome ,Evaluate Ampligen ,Exploring Ampligen ,New Drug Application ,Investigational New Drug ,Clinical Hold ,Pittsburgh Medical Center ,Western Equine Encephalitis Virus ,Human Drug Research ,Final Safety Report ,Severe Adverse Events ,Complete Response ,Review Board ,Orphan Drug Product Designation ,Medicines Agency ,Cost Recovery Authorization ,Healthcare Research ,Toll Like Receptor ,States Adopted Names Council ,Expanded Access ,Early Access ,Special Access Programs ,Disease Control ,Ovarian Cancer Specialized Program ,Research Excellence ,Pittsburgh School ,Multiple Ampligen ,Advanced Recurrent Ovarian Cancer ,Clinical Benefit Rate ,Objective Response Rates ,Triple Negative Breast Cancer ,Cancer Metastatic ,Cancer Trial ,Refractory Melanoma ,Pancreatic Cancer ,Nebraska Medical Center ,Ampligen Orphan Drug Designation ,Orphan Drug Designation ,Biopharma Europe ,Product Designation ,Induces Antiviral Activities ,Human Pancreatic Cancer Cells ,Medical Center ,Cancers Special Issue ,Innovative Therapies ,Systemic Immune Inflammation Index ,Lymphocyte Ratio ,Chronic Fatigue Immune Dysfunction Syndrome ,Patent Cooperation Treaty ,Material Transfer ,Smoore Technology ,State University ,Overseas Development Association ,Cancer Institute ,Viral Research ,Utah State ,Long Hauler ,Sponsor Agreement ,Start Up Agreement ,Human Challenge Trial ,Open Orphan ,Research Ethics Committee ,Pre Investigational New Drug Applications ,Clinical Research ,Park Comprehensive Cancer ,Orphan Medicinal Products Designation ,Cagliari Dipartimento ,Patent Application ,Contract Manufacturing Organizations ,Biologics License Application ,Renewed Sales ,Supply Agreement ,Marketing Authorization ,Early Access Approvals ,Impatients Agreement ,First Commercial Sale ,Tech Employees ,Trust Agreement ,Accounting Pronouncements ,Recent Accounting ,Accounting Policies ,Critical Accounting ,Registration Statement ,Edgar Online ,Aim Immunotech Inc Stock Exchange ,News ,Information ,Press Release ,Special ,Vote ,Egarding ,Statements ,N ,This ,Report ,Ucontain ,Ithin ,F ,Section ,27a ,The ,Securities ,Fact ,End ,1e Aim Us00901b1052 ,